Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MALT1 | Q9UDY8 | 4/20 | 0.34 |
| ▸ | NTRK1 | P04629 | 9/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | KAT7 | O95251 | 1/20 | 0.32 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.32 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.32 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.32 |
| ▸ | TTK | P33981 | 1/20 | 0.32 |
| ▸ | F9 | P00740 | 1/20 | 0.31 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14698445 | 0.81 | ALDH1A1 (0.39) | NTRK1 | |
| SCHEMBL14698293 | 0.81 | MALT1 (0.34) | MALT1SCN5ASCN9A | |
| SCHEMBL14698291 | 0.81 | MALT1 (0.34) | MALT1SCN5ASCN9A | |
| SCHEMBL14698209 | 0.72 | SCN5A (0.31) | RAB9ASCN5ASCN9A | |
| SCHEMBL14698210 | 0.72 | SCN5A (0.31) | RAB9ASCN5ASCN9A | |
| SCHEMBL14698211 | 0.72 | SCN5A (0.31) | RAB9ASCN5ASCN9A | |
| SCHEMBL10124234 | 0.72 | DHODH (0.30) | — | |
| SCHEMBL14697943 | 0.71 | KDM4E (0.41) | SCN5ASCN9A | |
| SCHEMBL14698223 | 0.71 | METAP2 (0.38) | MALT1SCN5ASCN9A | |
| SCHEMBL19461184 | 0.70 | ENPP2 (0.32) | MALT1NTRK1KAT7KAT6AKAT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140171316-A1 | ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2014-06-19 | — | — | US | disclosed |
| EP-2742038-A1 | ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2014-06-18 | — | — | EP | disclosed |
| WO-2013024006-A1 | ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2013-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140171316-A1 | ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | ANTXR2, NQO2, AAAS | MALT1 2645/4885NTRK1 3776/4885RAB9A 1446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.